Steroid Dosage for Pediatric Acute Urticaria Refractory to Antihistamines
For pediatric patients with acute urticaria not responding to H1-antihistamines, use a short 3-day course of oral prednisolone at a weight-adjusted dose (approximately 1 mg/kg/day, maximum 50 mg daily), though lower doses are often effective. 1
Dosing Algorithm
The British guideline provides adult dosing (prednisolone 50 mg daily for 3 days) but explicitly notes that "lower doses are often effective" 1. For pediatric patients:
- Weight-based approach: Start with approximately 1 mg/kg/day of prednisolone
- Maximum dose: Do not exceed 50 mg daily (adult dose)
- Duration: 3 days is typically sufficient for acute urticaria
- Timing: Use only when symptoms are intolerable or there is minimal/no response to antihistamines
Critical Context and Caveats
Short courses only for acute urticaria. The guidelines are emphatic that long-term corticosteroids should NOT be used in chronic urticaria (Strength of recommendation A) 1. The exception is very selected cases under regular specialist supervision, or specific conditions like urticarial vasculitis requiring 3-4 week tapering courses 1.
Evidence limitations. Recent systematic reviews reveal that the added benefit of corticosteroids to antihistamines in acute urticaria is actually unclear 2. A 2024 meta-analysis found that corticosteroids likely improve urticaria activity by only 2.2% absolute difference in patients with high antihistamine responsiveness (NNT=45), though the benefit increases to 14-15% in patients with lower antihistamine response (NNT=7) 3. Importantly, corticosteroids also likely increase adverse events in approximately 15% more patients 3.
Practical Considerations
Assess antihistamine response first. Before adding steroids, ensure the child has received adequate antihistamine therapy. Second-generation H1-antihistamines are preferred and can be increased up to 4-fold the standard dose if needed 4, 5.
Pediatric-specific data is limited. The guideline explicitly states that dosing varies for younger children and recommends consulting relevant data sheets before prescribing 1. Most evidence comes from adult studies, with pediatric recommendations extrapolated.
Reserve for severe cases. Given the modest benefit and increased adverse effects, reserve corticosteroids for cases where symptoms are truly intolerable or there is complete antihistamine failure. The 2024 systematic review concluded that the state-of-the-art management of acute urticaria remains unclear due to limited high-quality evidence 2.
Alternative Approach for Chronic Urticaria
If urticaria persists beyond 6 weeks (chronic urticaria), do not use long-term corticosteroids. Instead, follow the stepped approach: increase second-generation H1-antihistamines up to 4-fold, then add omalizumab if refractory 4, 6. Pediatric patients generally respond better to antihistamines than adults 7, and omalizumab has shown excellent efficacy in antihistamine-refractory cases 8, 7.